4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-23-046402
Director bought 250,000 shares at an average $1.30 ($325,737)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lamond David Director | 2023-08-15 | Purchase | +107,886 | $1.32 | $142,410 | 1,954,995 | I |
| Lamond David Director | 2023-08-16 | Purchase | +117,348 | $1.29 | $151,379 | 2,072,343 | I |
| Lamond David Director | 2023-08-17 | Purchase | +24,766 | $1.29 | $31,948 | 2,097,109 | I |
| Open-market purchases · 250,000 sh · avg $1.30 · $325,737 | |||||||
Loading xslF345X05/doc4.xml…